Daniel Clark

Stock Analyst at Leerink Partners

(n/a)
# 4,585
Out of 4,810 analysts
3
Total ratings
n/a
Success rate
-12.88%
Average return

Stocks Rated by Daniel Clark

Elanco Animal Health
Dec 2, 2024
Initiates: Market Perform
Price Target: $14
Current: $8.24
Upside: +69.90%
IDEXX Laboratories
Dec 2, 2024
Initiates: Outperform
Price Target: $500
Current: $404.02
Upside: +23.76%
Zoetis
Dec 2, 2024
Initiates: Outperform
Price Target: $215
Current: $149.22
Upside: +44.08%